SCHEMBL4697104

SCHEMBL4697104

COc1ccc(NC(=O)c2ccc(C)c(N)c2)cc1C(F)(F)F.Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1N.Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1Cl.Nc1cccc(C(=O)Nc2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.52
MAPT P10636 6/20 0.51
LMNA P02545 2/20 0.51
GAA P10253 2/20 0.51
RAB9A P51151 1/20 0.51
BTK Q06187 4/20 0.49
LCK P06239 2/20 0.47
BLK P51451 1/20 0.47
KIT P10721 2/20 0.47
KDR P35968 2/20 0.47
MAPK14 Q16539 2/20 0.47
CYP2C9 P11712 1/20 0.47
BRAF P15056 1/20 0.47
POLB P06746 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
TAS1R2 Q8TE23 1/20 0.45
KDM4E B2RXH2 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3085908 0.83 MAPT (0.57) MAPTLMNAGAARAB9ACYP2C9
SCHEMBL3300398 0.79 MAPT (0.54) MAPTLMNAGAARAB9ACYP2C9
SCHEMBL2313285 0.79 MAPT (0.68) PTGS1MAPTRAB9ALCKKIT
SCHEMBL4697489 0.79 MAPT (0.68) PTGS1MAPTLMNARAB9ALCK
SCHEMBL22025008 0.78 MAPT (0.64) PTGS1MAPTLMNARAB9APOLB
SCHEMBL13472574 0.77 MAPT (0.60) MAPTLMNAGAARAB9ABTK
SCHEMBL2492831 0.75 PTGS1 (0.70) PTGS1MAPTLMNARAB9ABTK
SCHEMBL374471 0.75 PTGS1 (0.70) PTGS1MAPTLMNAGAARAB9A
SCHEMBL4463935 0.75 PTGS1 (0.89) PTGS1MAPTLMNARAB9ABTK
SCHEMBL15127740 0.74 POLB (0.69) PTGS1MAPTLMNARAB9ABTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963327-A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS Novartis AG (CH) 2008-09-03 EP disclosed
WO-2007062805-A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS NOVARTIS AG (CH) 2007-06-07 WO disclosed